Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy
This study has been completed.
Study NCT00568035   Information provided by Quigley Pharma, Inc.
First Received: December 3, 2007   Last Updated: January 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Neuropathy
Additional conditions recognized in this trial
Diabetic Neuropathies
More general conditions related to this trial
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Nervous System Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Interventions listed in this trial
QR-333
Sponsors listed in this trial
Quigley Pharma, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services